Top Markets
Coin of the day
BioDelivery Sciences International, Inc. BioDelivery Sciences International, Inc.

BioDelivery Sciences International, Inc.

BDSI
Hisse Senetlerindeki Sıralama #16145
BioDelivery Sciences International, Inc. (BDSI) is a specialized pharmaceutical... BioDelivery Sciences International, Inc. (BDSI) is a specialized pharmaceutical firm dedicated to the advancement and commercialization of therapeutic products designed for long-term health conditions, serving markets both within the United States and internationally. The company's product offerings leverage its proprietary BioErodible MucoAdhesive drug delivery system—a slender, dissolving polymer film intended for application to the inner cheek—in addition to other drug administration methodologies. Its portfolio includes several key products: BELBUCA, a buprenorphine buccal film, is utilized for the ongoing management of persistent pain. Symproic functions as a peripherally acting mu-opioid receptor antagonist, specifically addressing opioid-induced constipation in adult patients suffering from chronic non-cancer pain. This also covers individuals whose chronic pain is a result of prior cancer or its treatment, provided they do not require frequent increases in opioid dosage. ELYXYB, an oral solution containing celecoxib, provides treatment for adult migraines, irrespective of the presence of an aura. ONSOLIS, a soluble fentanyl film administered buccally, is intended for the management of sudden, severe "breakthrough" pain experienced by cancer patients. Founded in 1997, BioDelivery Sciences International, Inc. is headquartered in Raleigh, North Carolina. As of March 18, 2022, the company operates as a subsidiary of Collegium Pharmaceutical, Inc.
Hisse Fiyatı
$5.59
Son senkronizasyon: 2022-03-31
Piyasa Değeri
$310.83M
Değişim (1 gün)
0.00%
Değişim (1 yıl)
0.00%
Ülke
US
Ticaret BioDelivery Sciences International, Inc. (BDSI)

Kategori

BioDelivery Sciences International, Inc. (BDSI) için tedavüldeki hisse sayısı
September 2026 itibarıyla tedavüldeki hisse sayısı: 0
BioDelivery Sciences International, Inc. şirketinin son finansal raporlarına ve hisse fiyatına göre, mevcut tedavüldeki hisse sayısı 0'dir. September 2026 sonunda şirketin 0 tedavüldeki hissesi vardı. Tedavüldeki hisse sayısı genellikle hisse bölünmeleri ve hisse geri alımları ile etkilenir.
BioDelivery Sciences International, Inc. (BDSI) için 2026 - 2026 tarihleri arasındaki hisse geçmişi
Her yıl sonunda tedavüldeki hisse sayısı
Yıl Tedavüldeki Hisse Sayısı Değiştir
Sağlanan tarihler için yeterli veri yok.
Benzer şirketler veya rakipler için tedavüldeki hisse sayısı